The primary factors that are anticipated to obstruct the growth of the global Pharmacogenomics Market include things like a lack of highly skilled and trained healthcare professionals to conduct the pharmacogenomics diagnostics test and a lack of pharmacogenomics information in the electronic systems used by healthcare professionals. For instance, in Frontiers, a publisher of peer-reviewed open access scientific publications, healthcare practitioners lack proper pharmacogenomics training and education and are gravely concerned about the lack of evidence-based therapeutic guidelines. The low level of pharmacogenomics integration is largely due to a lack of resources, including laboratory equipment, infrastructure needs for pharmacogenomics, and knowledgeable and highly trained healthcare workers.
Read more @ https://creativeedge16.blogspot.com/2022/12/pharmacogenomics-market-outlook.html
